Redeye’s analyst just published a Research Update on OncoZenge.
Click here to read the article
Make sure to add OncoZenge to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.
This is a press release from Redeye - Nordic Growth. www.redeye.se
Attachments
OncoZenge (Q1 Review): Final CTA approval received, initiating pivotal study
© Modular Finance, source Nordic Press Releases